Icon PLC IJF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IJF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- €276.40
- Day Range
- €278.80–287.40
- 52-Week Range
- €101.00–311.20
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €23.76 Bil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- 25.04
- Price/Sales
- 3.11
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 41,150
- Website
- https://www.iconplc.com
Competitors
Valuation
|
Metric
|
IJF
|
MEDP
|
FTRE
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.04 | 41.50 | 65.37 |
Price/Book Value | 2.69 | 18.78 | 1.86 |
Price/Sales | 3.11 | 6.60 | 1.04 |
Price/Cash Flow | 19.17 | 36.49 | 26.55 |
Price/Earnings
IJF
MEDP
FTRE
Financial Strength
|
Metric
|
IJF
|
MEDP
|
FTRE
|
|---|---|---|---|
Quick Ratio | 1.16 | 0.59 | 1.52 |
Current Ratio | 1.21 | 0.64 | 1.62 |
Interest Coverage | 3.37 | 688.87 | 1.02 |
Quick Ratio
IJF
MEDP
FTRE
Profitability
|
Metric
|
IJF
|
MEDP
|
FTRE
|
|---|---|---|---|
Return on Assets (Normalized) | 4.85% | 21.26% | 1.15% |
Return on Equity (Normalized) | 9.19% | 67.47% | 2.40% |
Return on Invested Capital (Normalized) | 8.41% | 49.10% | 3.06% |
Return on Assets
IJF
MEDP
FTRE
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Ygnpdpyln | Rmhx | $209.3 Bil | |
DHR
| Danaher Corp | Wpyhglcsw | Dnmkxj | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Qjdrdqpwv | Mzcdytm | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Chkcmbymt | Hrcrcp | $41.5 Bil | |
A
| Agilent Technologies Inc | Rwknvhxrb | Nqr | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Bmygvdbyx | Srnlgk | $26.5 Bil | |
ICLR
| Icon PLC | Mpcchtkt | Yybwbf | $24.8 Bil | |
ILMN
| Illumina Inc | Ywcqjsbpv | Yzzrgv | $19.5 Bil | |
WAT
| Waters Corp | Wylpcfmwj | Xxcnn | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Bhzkjrjcrx | Cmylrl | $16.7 Bil |